CD4, CD20 and PD-L1 as Markers of Recurrence in Non-Muscle-Invasive Bladder Cancer.

Semeniuk-Wojtas, Aleksandra; Modzelewska, Magdalena; Poddebniak-Strama, Karolina; Kolaczynska, Sylwia; Lubas, Arkadiusz; Górnicka, Barbara; Jakiela, Anna; Stec, Rafal

Semeniuk-Wojtas, Aleksandra; Modzelewska, Magdalena; Poddebniak-Strama, Karolina; Kolaczynska, Sylwia; Lubas, Arkadiusz; Górnicka, Barbara; Jakiela, Anna; Stec, Rafal.

Afiliação

Semeniuk-Wojtas A; Oncology Department, Medical University of Warsaw, 02-091 Warsaw, Poland.
Modzelewska M; Pathomorphology Department, Medical University of Warsaw, 02-091 Warsaw, Poland.
Poddebniak-Strama K; Oncology Department, 4 Military Clinical Hospital with a Polyclinic, 53-114 Wroclaw, Poland.
Kolaczynska S; Oncology Department, 4 Military Clinical Hospital with a Polyclinic, 53-114 Wroclaw, Poland.
Lubas A; Department of Internal Medicine, Nephrology and Dialysis, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
Górnicka B; Pathomorphology Department, Medical University of Warsaw, 02-091 Warsaw, Poland.
Jakiela A; Oncology Department, 4 Military Clinical Hospital with a Polyclinic, 53-114 Wroclaw, Poland.
Stec R; Oncology Department, Medical University of Warsaw, 02-091 Warsaw, Poland.

Cancers (Basel) ; 15(23)2023 Nov 22.

Article em En | MEDLINE | ID: mdl-38067231

Palavras-chave

CD20; CD4; NMIBC; PD-L1; bladder cancer; immune cells; tumor microenvironment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google